Literature DB >> 20123529

[Prostate cancer management and factors associated with radical prostatectomy in France in 2001].

J Jegu1, B Tretarre, M Velten, A-V Guizard, A Danzon, A Buemi, M Colonna, A-M Kadi-Hanifi, O Ganry, F Molinie, S Bara, X Rebillard, P Grosclaude.   

Abstract

INTRODUCTION: Prostate cancer was the most common cancer in men in France in 2005, and the second cause of male death from cancer. In this study, we analyzed clinical characteristics of patients with prostate cancer diagnosed in France in 2001 with a focus on therapeutic management of localized prostate cancers. PATIENTS AND METHODS: A total of 2181 cases of prostate cancer diagnosed in 2001 from 11 French counties covered by a cancer registry were analyzed. A descriptive study of the clinical characteristics of patients was performed. Parameters studied included age, county, TNM stage, PSA value, Gleason score, D'Amico prognostic group, Charlson's comorbidity index and initial treatment modalities. For localized cancers, multivariate logistic regression analysis identified factors associated with radical prostatectomy.
RESULTS: The proportion of localized prostate cancer (T1 or T2) was 86.6 %. The use of invasive curative treatment (radical prostatectomy and radiotherapy) was 58.4 % for localized cancers. Significant differences in therapeutic management were found between counties. Radical prostatectomy was associated with age at diagnosis, D'Amico prognostic group and the presence of comorbidities.
CONCLUSIONS: Most of prostate cancers diagnosed in France in 2001 were clinically localized and were treated by invasive therapy. The consequences of these practices remain to be determined given the limited evolution of many prostate cancers and the frequency of adverse events related to invasive treatments. Copyright 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20123529     DOI: 10.1016/j.purol.2009.09.004

Source DB:  PubMed          Journal:  Prog Urol        ISSN: 1166-7087            Impact factor:   0.915


  4 in total

1.  Assessment of cancers' diagnostic stage in a Deaf community - survey about 4363 Deaf patients recorded in French units.

Authors:  Vladimir Druel; Hélène Hayet; Laetitia Esman; Marie Clavel; Marie-Eve Rougé Bugat
Journal:  BMC Cancer       Date:  2018-01-23       Impact factor: 4.430

2.  Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: a population-based study.

Authors:  M de Camargo Cancela; H Comber; L Sharp
Journal:  Br J Cancer       Date:  2013-05-30       Impact factor: 7.640

3.  Pattern of care of prostate cancer patients across the Martinique: results of a population-based study in the Caribbean.

Authors:  Clarisse Joachim; Jacqueline Veronique-Baudin; Stephen Ulric-Gervaise; Jonathan Macni; Thierry Almont; Olivier Pierre-Louis; Lidvine Godaert; Moustapha Drame; Jean-Luc Novella; Karim Farid; Vincent Vinh-Hung; Patrick Escarmant
Journal:  BMC Cancer       Date:  2018-11-16       Impact factor: 4.430

4.  Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort.

Authors:  Magali Rouyer; Stéphane Oudard; Florence Joly; Karim Fizazi; Florence Tubach; Jérémy Jove; Clémentine Lacueille; Stéphanie Lamarque; Estelle Guiard; Aurélie Balestra; Cécile Droz-Perroteau; Annie Fourrier-Reglat; Nicholas Moore
Journal:  Br J Cancer       Date:  2019-11-13       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.